Delivery Order SPE2DB22D1106-SPE2DB25FFGN8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $22,386 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by military personnel for malaria prophylaxis. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $2,040.63 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100s, a pharmaceutical product used for malaria prophylaxis and treatment. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,343.16 on September 9, 2025, for Atovaquone-Proguanil 250-100 (100 tablets), with a completion date of September 10, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply needs. The order...
- The Defense Logistics Agency awarded a delivery order valued at $1,586.54 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 11, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The product being...
- The Defense Logistics Agency awarded a delivery order valued at $5,504.61 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 count) on August 11, 2025, with completion scheduled for August 12, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count units) valued at $2,350.53 under a firm fixed price contract. This antimalarial pharmaceutical product is being delivered to support military healthcare requirements, with the place of performance located in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $8,058.96 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 units. The contract, which represents a non-set-aside competitive award, is scheduled for completion by August 25, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order valued at $10,073.70 with an ultimate completion date of August 15, 2025. The contract is not set-aside and was competitively awarded. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the corporate headquarters...
- The Defense Logistics Agency awarded a $8,058.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was fulfilled from the company's place of performance in Conshohocken, Pennsylvania,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGN8Delivery Order
The Defense Logistics Agency (DLA) awarded a $5,267.04 delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used for malaria prevention and treatment in military populations. This firm fixed-price delivery order, awarded September 3, 2025, with completion targeted for September 4, 2025, represents a non-competitive set-aside contract awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement, with this delivery order fulfilled from its corporate office location in the same city. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this flexible contract vehicle, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 9/3/25 |